Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) /System xc-/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis
Ferroptosis is an important form of myocardial cell death in myocardial ischemia-reperfusion injury (MIRI). Naringenin (NAR), as a flavonoid, has a significant advantage in improving MIRI. But the regulatory effect and mechanism of NAR on ferroptosis in MIRI have not been reported. After the rats we...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Taylor & Francis Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/97979837daa74645b5854582f330dd98 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:97979837daa74645b5854582f330dd98 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:97979837daa74645b5854582f330dd982021-12-01T14:41:00ZNaringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) /System xc-/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis2165-59792165-598710.1080/21655979.2021.1995994https://doaj.org/article/97979837daa74645b5854582f330dd982021-12-01T00:00:00Zhttp://dx.doi.org/10.1080/21655979.2021.1995994https://doaj.org/toc/2165-5979https://doaj.org/toc/2165-5987Ferroptosis is an important form of myocardial cell death in myocardial ischemia-reperfusion injury (MIRI). Naringenin (NAR), as a flavonoid, has a significant advantage in improving MIRI. But the regulatory effect and mechanism of NAR on ferroptosis in MIRI have not been reported. After the rats were given NAR and induced to form myocardial ischemia-reperfusion (MI/R) injury, Tetrazolium chloride (TTC) staining was used to detect the myocardial infarction area of rats, and Hematoxylin-eosin (H&E) staining was used to detect myocardial injury. The markers of tissue inflammation were detected by ELISA. Serum creatine kinase Serum creatin kinase (CPK), Lactate dehydrogenase (LDH), and lipid peroxide (LPO) and oxidative stress related levels were measured. In addition, iron detection kits were used to detect total iron and Fe2+ levels in cardiac tissues, and western blot was used to detect the expression of ferroptosis-related proteins and the expression of nuclear factor-erythroid factor 2-related factor 2 (Nrf2) and glutathione peroxidase 4 (GPX4). At the cellular level, H9C2 cardiomyocytes were induced by hypoxia/reoxygenation (H/R), and ferroptosis inducer Erastin was administered to detect cell viability, ferroptosis-related indicators, oxidative stress related indicators, and expressions of Nrf2 and GPX4, to explore the mechanisms involved. NAR alleviated MI/R-induced pathological damage, inflammation and lipid peroxidation in myocardial tissue of rats. NAR adjusted the NRF2 /System xc – /GPX4 axis and improved ferroptosis. At the cellular level, ferroptosis inducer Erastin reversed the protective effect of NAR on H/R-induced H9C2 cardiomyocytes. In conclusion, NAR can alleviate MIRI by regulating the Nrf2/System xc-/GPX4 axis to inhibit ferroptosis.Shujun XuBingxin WuBiying ZhongLuoqi LinYining DingXiao JinZhiwei HuangMiaoyang LinHuanlin WuDanping XuTaylor & Francis Grouparticlenaringeninmyocardial ischemia/reperfusion injuryferroptosisnrf2/system xc-/gpx4 axisBiotechnologyTP248.13-248.65ENBioengineered, Vol 12, Iss 2, Pp 10924-10934 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
naringenin myocardial ischemia/reperfusion injury ferroptosis nrf2/system xc-/gpx4 axis Biotechnology TP248.13-248.65 |
spellingShingle |
naringenin myocardial ischemia/reperfusion injury ferroptosis nrf2/system xc-/gpx4 axis Biotechnology TP248.13-248.65 Shujun Xu Bingxin Wu Biying Zhong Luoqi Lin Yining Ding Xiao Jin Zhiwei Huang Miaoyang Lin Huanlin Wu Danping Xu Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) /System xc-/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis |
description |
Ferroptosis is an important form of myocardial cell death in myocardial ischemia-reperfusion injury (MIRI). Naringenin (NAR), as a flavonoid, has a significant advantage in improving MIRI. But the regulatory effect and mechanism of NAR on ferroptosis in MIRI have not been reported. After the rats were given NAR and induced to form myocardial ischemia-reperfusion (MI/R) injury, Tetrazolium chloride (TTC) staining was used to detect the myocardial infarction area of rats, and Hematoxylin-eosin (H&E) staining was used to detect myocardial injury. The markers of tissue inflammation were detected by ELISA. Serum creatine kinase Serum creatin kinase (CPK), Lactate dehydrogenase (LDH), and lipid peroxide (LPO) and oxidative stress related levels were measured. In addition, iron detection kits were used to detect total iron and Fe2+ levels in cardiac tissues, and western blot was used to detect the expression of ferroptosis-related proteins and the expression of nuclear factor-erythroid factor 2-related factor 2 (Nrf2) and glutathione peroxidase 4 (GPX4). At the cellular level, H9C2 cardiomyocytes were induced by hypoxia/reoxygenation (H/R), and ferroptosis inducer Erastin was administered to detect cell viability, ferroptosis-related indicators, oxidative stress related indicators, and expressions of Nrf2 and GPX4, to explore the mechanisms involved. NAR alleviated MI/R-induced pathological damage, inflammation and lipid peroxidation in myocardial tissue of rats. NAR adjusted the NRF2 /System xc – /GPX4 axis and improved ferroptosis. At the cellular level, ferroptosis inducer Erastin reversed the protective effect of NAR on H/R-induced H9C2 cardiomyocytes. In conclusion, NAR can alleviate MIRI by regulating the Nrf2/System xc-/GPX4 axis to inhibit ferroptosis. |
format |
article |
author |
Shujun Xu Bingxin Wu Biying Zhong Luoqi Lin Yining Ding Xiao Jin Zhiwei Huang Miaoyang Lin Huanlin Wu Danping Xu |
author_facet |
Shujun Xu Bingxin Wu Biying Zhong Luoqi Lin Yining Ding Xiao Jin Zhiwei Huang Miaoyang Lin Huanlin Wu Danping Xu |
author_sort |
Shujun Xu |
title |
Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) /System xc-/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis |
title_short |
Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) /System xc-/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis |
title_full |
Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) /System xc-/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis |
title_fullStr |
Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) /System xc-/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis |
title_full_unstemmed |
Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) /System xc-/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis |
title_sort |
naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (nrf2) /system xc-/ glutathione peroxidase 4 (gpx4) axis to inhibit ferroptosis |
publisher |
Taylor & Francis Group |
publishDate |
2021 |
url |
https://doaj.org/article/97979837daa74645b5854582f330dd98 |
work_keys_str_mv |
AT shujunxu naringeninalleviatesmyocardialischemiareperfusioninjurybyregulatingthenuclearfactorerythroidfactor2relatedfactor2nrf2systemxcglutathioneperoxidase4gpx4axistoinhibitferroptosis AT bingxinwu naringeninalleviatesmyocardialischemiareperfusioninjurybyregulatingthenuclearfactorerythroidfactor2relatedfactor2nrf2systemxcglutathioneperoxidase4gpx4axistoinhibitferroptosis AT biyingzhong naringeninalleviatesmyocardialischemiareperfusioninjurybyregulatingthenuclearfactorerythroidfactor2relatedfactor2nrf2systemxcglutathioneperoxidase4gpx4axistoinhibitferroptosis AT luoqilin naringeninalleviatesmyocardialischemiareperfusioninjurybyregulatingthenuclearfactorerythroidfactor2relatedfactor2nrf2systemxcglutathioneperoxidase4gpx4axistoinhibitferroptosis AT yiningding naringeninalleviatesmyocardialischemiareperfusioninjurybyregulatingthenuclearfactorerythroidfactor2relatedfactor2nrf2systemxcglutathioneperoxidase4gpx4axistoinhibitferroptosis AT xiaojin naringeninalleviatesmyocardialischemiareperfusioninjurybyregulatingthenuclearfactorerythroidfactor2relatedfactor2nrf2systemxcglutathioneperoxidase4gpx4axistoinhibitferroptosis AT zhiweihuang naringeninalleviatesmyocardialischemiareperfusioninjurybyregulatingthenuclearfactorerythroidfactor2relatedfactor2nrf2systemxcglutathioneperoxidase4gpx4axistoinhibitferroptosis AT miaoyanglin naringeninalleviatesmyocardialischemiareperfusioninjurybyregulatingthenuclearfactorerythroidfactor2relatedfactor2nrf2systemxcglutathioneperoxidase4gpx4axistoinhibitferroptosis AT huanlinwu naringeninalleviatesmyocardialischemiareperfusioninjurybyregulatingthenuclearfactorerythroidfactor2relatedfactor2nrf2systemxcglutathioneperoxidase4gpx4axistoinhibitferroptosis AT danpingxu naringeninalleviatesmyocardialischemiareperfusioninjurybyregulatingthenuclearfactorerythroidfactor2relatedfactor2nrf2systemxcglutathioneperoxidase4gpx4axistoinhibitferroptosis |
_version_ |
1718405009395154944 |